IRTC vs. AXNX, PRCT, MMSI, ICUI, TNDM, IART, NARI, HAE, GKOS, and ATEC
Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Axonics (AXNX), PROCEPT BioRobotics (PRCT), Merit Medical Systems (MMSI), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Integra LifeSciences (IART), Inari Medical (NARI), Haemonetics (HAE), Glaukos (GKOS), and Alphatec (ATEC). These companies are all part of the "surgical & medical instruments" industry.
iRhythm Technologies (NASDAQ:IRTC) and Axonics (NASDAQ:AXNX) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment.
99.5% of Axonics shares are held by institutional investors. 0.7% of iRhythm Technologies shares are held by insiders. Comparatively, 1.9% of Axonics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
iRhythm Technologies currently has a consensus price target of $134.00, indicating a potential upside of 30.50%. Axonics has a consensus price target of $70.73, indicating a potential upside of 5.12%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe iRhythm Technologies is more favorable than Axonics.
iRhythm Technologies received 215 more outperform votes than Axonics when rated by MarketBeat users. However, 67.18% of users gave Axonics an outperform vote while only 66.04% of users gave iRhythm Technologies an outperform vote.
iRhythm Technologies has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Comparatively, Axonics has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500.
Axonics has a net margin of -4.12% compared to iRhythm Technologies' net margin of -25.33%. Axonics' return on equity of -2.58% beat iRhythm Technologies' return on equity.
In the previous week, iRhythm Technologies had 1 more articles in the media than Axonics. MarketBeat recorded 14 mentions for iRhythm Technologies and 13 mentions for Axonics. iRhythm Technologies' average media sentiment score of -0.01 beat Axonics' score of -0.02 indicating that iRhythm Technologies is being referred to more favorably in the media.
Axonics has lower revenue, but higher earnings than iRhythm Technologies. Axonics is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
iRhythm Technologies and Axonics tied by winning 9 of the 18 factors compared between the two stocks.
Get iRhythm Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
iRhythm Technologies Competitors List
Related Companies and Tools
